Loading...

Change in stock symbol from GULDF to ALRDF

Published
11 Oct 25
Oxydoxy's Fair Value
US$0
n/aintrinsic discount
11 Oct
US$0.017
Loading
1Y
11.3%
7D
15.2%

Author's Valuation

US$0n/aintrinsic discount

Oxydoxy's Fair Value

Since the stock symbol was updated from GULDF to ALRDF, I am reposting my original post here.

I believe Defence Holdings PLC is quietly building one of the most unique microcap stories in the UK / NATO innovation space right now — and virtually no one in the U.S. markets seems to know it exists.

Formerly Guild Esports, the company has fully restructured, changed leadership, completed a capital raise, and pivoted into a “software-first defence platform”—targeting:

  • AI-enabled battlefield agents
  • Swarm drone coordination
  • Cyber/infrastructure defence
  • Influence & information operations

These aren’t buzzwords. They’re four verticals clearly laid out in a 5-year roadmap, and being tackled by a leadership team with ex-Microsoft Ventures, Royal Navy, Raytheon, and cyber-defence pedigree. The company recently uplisted to the London Stock Exchange Main Market, and just signed a strategic AI partnership with Whitespace, a sovereign UK defence infrastructure player—with initial MOD-facing deployments already underway.

More details available at their official site: https://www.defenceplc.com

What I’m Watching Next

  • Contract wins or MoUs with UK MOD / NATO partners
  • Expansion of AI agent deployments beyond UK to allied defence networks
  • Further uplisting moves, share consolidation, or major fund entry
  • U.S. visibility—media, analyst, ETF coverage, or public defence tech comparison

I believe this is a very early-stage opportunity in a space the UK and NATO are actively funding to reduce dependency on U.S. suppliers, and the market hasn’t caught on yet.

If you're watching defence, cyber, AI, or sovereign tech... this might be worth tracking.

Again — do your own research. Just sharing what I see.

How well do narratives help inform your perspective?

Disclaimer

The user Oxydoxy has a position in OTCPK:ALRT.F. Simply Wall St has no position in any of the companies mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The author of this narrative is not affiliated with, nor authorised by Simply Wall St as a sub-authorised representative. This narrative is general in nature and explores scenarios and estimates created by the author. The narrative does not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company's future performance and are exploratory in the ideas they cover. The fair value estimates are estimations only, and does not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that the author's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives